Top Markets
Coin of the day
Panacos Pharmaceuticals, Inc. Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANC
Rang in Aktien #42054
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm... Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$5.37K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Panacos Pharmaceuticals, Inc. (PANC)

Kategorie

Kursverlauf für Panacos Pharmaceuticals, Inc. (PANC)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $0.40 am 2005-03-01
Kursverlauf der Aktie von Panacos Pharmaceuticals, Inc. von 2005 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -4.50%
2024 9,900.00%
2023 0.00%
2022 -90.00%
2021 -99.30%
2020 15,555.94%
2019 389.88%
2018 -6.29%
2017 143.90%
2016 -33.62%
2015 23.53%
2014 -99.79%
2013 -38.47%
2012 117.54%
2011 -41.33%
2010 -73.55%
2009 -84.59%
2008 -87.50%
2007 -78.30%
2006 -27.11%
2005 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.52%
KR